Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02743078 |
Title | Optune Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | RTOG Foundation, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California, San Diego | La Jolla | California | 92093 | United States | Details | |
University of California Irvine, Chao Family Comprehensive Cancer Center | Orange | California | 92868 | United States | Details | |
Miami Cancer Institute at Baptist Health | Miami | Florida | 33176 | United States | Details | |
UF Health Cancer Center at Orlando Health | Orlando | Florida | 32806 | United States | Details | |
Emory University | Atlanta | Georgia | 30322 | United States | Details | |
Washington University School of Medicine | Saint Louis | Missouri | 63100 | United States | Details | |
University of Rochester | Rochester | New York | 14642 | United States | Details | |
Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | United States | Details | |
Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | United States | Details | |
Medical University of South Carolina | Charleston | South Carolina | 29425 | United States | Details | |
Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | United States | Details |